Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
暂无分享，去创建一个
Kenneth J. Smith | D. Bellissimo | E. Kraut | A. Leavitt | A. Althouse | T. Nichols | M. Ragni | R. Sidonio | L. Malec | E. Merricks | S. Rothenberger | R. Pruthi | C. Philipp | G. Koerbel | R. Kulkarni | D. Angelini | A. Wheeler | Michael Meyer | D. Nance | N. Hwang | Robert Feldman | D. Ivanco | F. Xavier | Craig D. Seaman | Joseph Lasky | Nicoletta C Machin | Gregory Humphreys | Deborah Vehec | Allison P. Wheeler | Dana Ivanco | Nina Hwang